Is Smallpox Set for a Comeback?

Smallpox has the kind of reputation that makes modern viruses look almost polite. For centuries, it killed, scarred, blinded, and terrified entire populations. Then science, logistics, and a whole lot of determined public-health work pulled off one of humanity’s greatest flexes: wiping it out. Which is why the question keeps popping up in headlines, social feeds, and late-night doom-scrolling sessions: Is smallpox set for a comeback?

The smart answer is this: not naturally, and not in the ordinary way people imagine. Smallpox is not quietly circulating in the background, waiting for a dramatic reboot like a canceled TV show that somehow lands three new seasons. But experts still take it seriously because the variola virusthe virus that causes smallpoxremains part of biodefense planning, vaccine policy, and emergency preparedness.

That means the real story is more interesting than a simple yes-or-no headline. Smallpox is not poised to return like flu season. Still, it has not vanished from strategic thinking, and that distinction matters. A lot.

The Short Answer: No, Smallpox Is Not Quietly “Coming Back”

If by “comeback” you mean a natural resurgence, the answer is no. Smallpox was declared eradicated in 1980 after the last known natural case was recorded in Somalia in 1977. Unlike diseases that can hide in animal populations and leap back into people, smallpox has no known animal reservoir. That is one of the main reasons eradication was possible in the first place.

So smallpox is not lurking in raccoons, squirrels, mosquitoes, or some suspicious cave with terrible Yelp reviews. Nature does not appear to have a backup copy.

That said, public-health agencies still plan for smallpox because two uncomfortable realities remain. First, limited variola virus stocks are still retained in authorized high-security repositories for research. Second, experts have long considered smallpox a potential bioterrorism threat. In other words, the concern is not a natural comeback. The concern is an unnatural one.

Why Smallpox Was So Feared in the First Place

To understand why people still pay attention to an eradicated disease, it helps to remember what smallpox actually did. This was not a mild rash and a few grumpy days on the couch. Smallpox typically began with fever, exhaustion, severe body aches, and headache, followed by the famous rash that progressed into deep, firm lesions. Survivors were often left with lasting scars, and some lost their vision.

Historically, the deadliest common formvariola majorkilled roughly 30% of people infected. That is part of why smallpox occupies such a large space in medical history. It was not merely contagious; it was catastrophic.

Transmission also made it formidable. Smallpox spread mainly through fairly prolonged face-to-face contact, especially after sores appeared in the mouth and throat. Contaminated bedding, clothing, and other materials could also play a role. People remained contagious until the last scab fell off. In a world before rapid diagnostics, modern isolation protocols, and international surveillance networks, that was a public-health nightmare with a bad attitude.

Why a Natural Comeback Is Extremely Unlikely

No Animal Reservoir Means No Natural Hideout

Many infectious diseases are stubborn because they can survive in animals even when human transmission drops. Smallpox was different. Variola infected humans only. That gave public-health teams a huge strategic advantage: if you stop transmission in people, you stop the disease. Full stop.

Routine Global Transmission Ended Decades Ago

Smallpox is not simmering in a corner of the globe. There has been no naturally occurring smallpox for decades. That matters because a disease cannot “re-emerge” naturally if it is no longer circulating in nature at all.

Eradication Was Not SymbolicIt Was Real

Sometimes people hear “eradicated” and mentally translate it as “rare.” That is not what it means. Eradication means ongoing natural transmission was eliminated worldwide. Smallpox remains the only human infectious disease to achieve that distinction, which is both impressive and a little bit intimidating for every other pathogen still acting up.

So Why Do Experts Still Worry About It?

The Bioterrorism Question Has Never Fully Gone Away

The biggest reason smallpox still shows up in preparedness plans is the possibility of deliberate release. Health agencies in the United States have said for years that, while unlikely, smallpox remains a concern because variola virus could theoretically be used as a biological weapon.

This is why the disease sits in that unusual category of “not circulating, but still strategically important.” It is gone from nature, but not gone from emergency planning.

The Virus Still Exists in Restricted Research Settings

WHO oversight continues for the two authorized variola repositories. That fact makes some people uneasy, and honestly, that reaction is understandable. But the reason these repositories remain part of global policy is tied to research on diagnostics, vaccines, antivirals, and preparedness.

In plain English: the world does not keep those stocks because it misses the 1700s. It keeps them because preparedness decisions involve trade-offs, and one side of that debate is whether limited controlled research still offers public-health value.

Most People Today Are Not Routinely Vaccinated Against Smallpox

Routine smallpox vaccination for the general public in the United States ended in the 1970s, and worldwide routine vaccination stopped after eradication. That means a large share of the population today has never received a smallpox vaccine at all. Older adults may still have a small round scar on the upper arm from earlier vaccination, but that scar is not a magic force field for the entire modern era.

So while smallpox is not naturally reappearing, the population is also not walking around with fresh, broad immunity to it. That is exactly why stockpiles and response plans still matter.

If Smallpox Reappeared, Would We Be Defenseless?

No. And this is where the story gets much less apocalyptic than clickbait headlines usually suggest.

Vaccines Still Exist

The United States keeps smallpox vaccines in the Strategic National Stockpile. Two licensed vaccines are central to current planning: ACAM2000 and JYNNEOS.

They are not interchangeable in every situation. ACAM2000 is a replication-competent vaccinia vaccine, which means it can cause more significant side effects and requires careful handling. JYNNEOS is a non-replicating vaccine and was developed in part to offer a safer option for people who might not be good candidates for older-style vaccines.

That difference matters. In a real emergency, vaccine strategy would not be “everyone line up and hope for the best.” Officials would weigh exposure risk, medical history, contraindications, and the safety profile of each product.

Antiviral Treatments Exist Too

Two FDA-approved drugs are part of smallpox preparedness: tecovirimat (TPOXX) and brincidofovir (TEMBEXA). These approvals were based on animal data and human safety studies because, for obvious ethical reasons, nobody is running classic human challenge trials for smallpox. That would be less “clinical research” and more “instant global outrage.”

These drugs are not a reason to be casual about the disease, but they do mean smallpox response is not stuck in the era of candlelight and bad luck. Modern medicine has tools.

Public-Health Response Would Move Fast

Another reason smallpox is less likely to spiral out of control than people assume is that the response playbook is not theoretical. Decades of planning exist for isolation, testing, contact tracing, and targeted vaccination. Smallpox eradication itself was achieved through surveillance and containment, not just blanket vaccination alone.

That history matters because it shows public health is not starting from zero. It is starting from one of the most studied eradication campaigns in human history.

Would Smallpox Spread Like COVID-19?

Not exactly. The comparison is tempting because COVID trained everyone to imagine every pathogen as a fast-moving global disruption machine. But smallpox behaves differently.

For one thing, people with smallpox were generally not contagious during the incubation period. Symptoms usually appeared around 10 to 14 days after infection, and contagiousness began when lesions appeared in the mouth and throat during the early rash stage. That means transmission was more closely linked to visible illness than with a virus like SARS-CoV-2, which can spread before symptoms.

Also, smallpox’s rash was distinctive. That does not make it harmlessfar from itbut it does make it easier to recognize than infections that can initially look like a dozen ordinary things. Visibility gives public health an advantage.

At the same time, nobody should confuse “different from COVID” with “not serious.” A disease with a high fatality rate, visible lesions, and the ability to spread through close contact and contaminated materials would still be a major emergency.

What About MpoxDoes That Mean Smallpox Is Sneaking Back?

No. Mpox is not smallpox. The two diseases belong to the same broader orthopoxvirus family, which is why smallpox vaccines can offer cross-protection in some contexts. But mpox and smallpox are not the same virus, not the same disease, and not the same level of threat.

What the mpox outbreaks did do, however, was remind the public that orthopoxviruses still matter. They also renewed attention to vaccines such as JYNNEOS and to the value of being prepared for pox-family diseases. So if mpox made you suddenly remember that smallpox once existed, congratulations: you have joined the club of people who discovered that history is not actually asleep, just waiting for a headline.

Myths That Need to Retire Gracefully

Myth 1: Smallpox can naturally “come back” at any moment.

Reality: There is no evidence of natural circulation. The realistic concern is deliberate release or an extraordinarily rare security failure, not nature casually reintroducing variola.

Myth 2: A vaccine scar means permanent invincibility.

Reality: Historical protection from smallpox vaccination is strong, but immunity is not a superhero cape that necessarily lasts at peak strength forever. Long-term protection can decrease over time.

Myth 3: Because smallpox is eradicated, planning for it is overkill.

Reality: Preparedness exists precisely because the disease was so devastating and because the consequences of even one confirmed case would be enormous.

Myth 4: If smallpox ever returned, society would instantly collapse.

Reality: The threat would be serious, but today’s response infrastructure includes stockpiled vaccines, antiviral drugs, containment planning, laboratory capacity, and decades of biodefense strategy.

What a “Comeback” Would Actually Mean

Here is the key point: if smallpox ever reappeared, it would not look like some forgotten germ randomly wandering back into town. It would almost certainly mean one of a very small number of highly unusual scenariosmost notably deliberate release or a grave biosafety or biosecurity event.

That is why public-health experts are careful with language. They do not usually talk about smallpox as if it were poised to “return” on its own. They talk about preparedness, countermeasures, stockpiles, and response capacity. Those words are less dramatic than “comeback,” but they are much closer to reality.

What Regular Readers Should Take Away

If you are not a laboratory worker, emergency planner, or infectious-disease specialist, here is the practical takeaway: there is no evidence that smallpox is naturally making a comeback. It is not circulating in the general public, and it is not a routine everyday risk.

At the same time, it would be foolish to shrug it off as ancient history with a powdered wig. The world continues to prepare for smallpox because it was uniquely dangerous, because routine vaccination ended long ago, and because a disease does not need to be common to deserve serious planning. It just needs to be catastrophic enough.

So, is smallpox set for a comeback? Nonot in the natural sense. But as a preparedness priority, a biodefense concern, and a reminder of what vaccination can accomplish, smallpox never really left the conversation.

And maybe that is the better lesson here. Smallpox is not the monster under the bed. It is the framed warning label on the wall: a reminder of what humanity beat once, and what it should never be careless enough to invite back.

Extended Reflections: Human Experiences Around the Fear of Smallpox

One reason the question “Is smallpox set for a comeback?” still hits a nerve is that smallpox lives in public memory in a very human way. For many older adults, the disease is remembered less through textbooks than through the little round vaccine scar on an upper arm. That scar is like a tiny historical document. It tells a story about a time when vaccination was not an abstract debate topic or a social-media battlefield, but a routine expectation because the alternative was considered much worse.

For younger generations, the experience is different. Smallpox often feels like something from black-and-white photographs, museum exhibits, or high school history lessons sitting between the Industrial Revolution and a chapter everyone forgot to read. Then a public-health emergency happensanthrax fears, mpox outbreaks, COVID, or renewed bioterrorism discussionsand suddenly the word “smallpox” sounds less antique and more unnervingly current.

That emotional whiplash is part of the modern experience of the disease. Most people have never seen a case, never met a survivor, and never lived in a world where a smallpox outbreak was a daily fear. Yet the disease still carries enormous symbolic weight. It represents the worst-case scenario people imagine when they hear the phrase “high-consequence pathogen.” In that sense, smallpox occupies a strange psychological category: absent in real life, but very present in the imagination.

Public-health workers often experience it differently still. For them, smallpox is not really a ghost story. It is a planning scenario. It is training material, preparedness language, vaccine storage policy, lab protocol, and tabletop exercises. That can sound cold, but it is actually reassuring. The professionals who think about dangerous pathogens for a living do not spend their days dramatically gasping into the middle distance. They build systems. They review stockpiles. They refine guidance. They rehearse decisions before a crisis ever arrives.

There is also a broader social experience attached to smallpox: it reminds people what successful prevention looks like. When the public only notices a disease during an emergency, it is easy to think health systems exist mostly to react. Smallpox tells the opposite story. Its history is about prevention, coordination, surveillance, vaccination, and relentless follow-through. In other words, it is about boring competence winning the championship.

The irony is that success can make people forget what success prevented. Once a disease disappears, the memory of its damage fades. Scars are replaced by statistics. Fear turns into trivia. Then, when headlines ask whether smallpox could return, many people are left trying to emotionally process a disease they know just enough about to find terrifying, but not enough about to understand calmly.

That is why the best modern experience with smallpox is not panic. It is perspective. Respect the history. Understand the risk. Appreciate the tools we have now. And remember that one of the greatest public-health victories in history happened because people did not treat prevention as optional or preparation as paranoia. They treated both as necessary. That mindset is not old-fashioned. It is the reason smallpox is a question instead of a current outbreak.

Conclusion

Smallpox is not naturally creeping back into human life, and there is no sign that routine transmission has somehow restarted in secret. But the question remains relevant because smallpox sits at the intersection of history, biodefense, vaccines, and public trust. It is both a triumph of eradication and a warning about complacency.

The right conclusion is neither panic nor dismissal. It is informed seriousness. Smallpox is not set for a natural comeback. Yet the world is wise to keep one eye on preparedness, because the very reasons smallpox became legendary are the same reasons no one wants to be caught underestimating it now.